Clinical Trials Logo

Filter by:
NCT ID: NCT06220474 Recruiting - Dry Eye Syndromes Clinical Trials

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The goal of this prospective, 24-week, double-masked, randomized, sham-controlled clinical trials to compare clinical efficacy and safety of RF and MGX with MGX alone in patients with meibomian gland dysfunction-related dry eye disease. The main question it aims to answer is whether radiofrequency treatment and meibomian gland expression is more effective in improving tear breakup time, as measured using non-invasive video keratography, compared with meibomian gland expression alone, in patients with refractory meibomian gland dysfunction-related dry eye disease. Participants will be divided into two groups, one group will receive RF treatment followed with MGX and another will receive sham treatment with MGX.

NCT ID: NCT06217601 Recruiting - Aging Well Clinical Trials

Impact Evaluation of the Digital Connect Project for Homebound Older Adults

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate the impact of the Digital Connect Project on increasing functional capacity defined by the WHO-ICOPE and health-related quality of life (HRQL) among homebound older adults.

NCT ID: NCT06214260 Recruiting - Endometriosis Clinical Trials

Menstrual Blood Proteomic Profile in Women With Endometriosis (PROTEO-ENDO) Study

PROTEO-ENDO
Start date: November 15, 2023
Phase:
Study type: Observational

In this prospective case control study a total of 66 women (33 women with endometriosis) and (33 healthy women) will be recruited. The main objective of the study is to investigate the proteomic profile of menstrual blood in women with endometriosis compared to controls. Additionally, differentially expressed proteins will be investigated across different stages, clinical presentations, and subtypes of endometriosis

NCT ID: NCT06207006 Recruiting - Cancer Clinical Trials

E-intervention on Subclinical Fear of Cancer Recurrence

Start date: May 2, 2024
Phase: N/A
Study type: Interventional

The present study aims to adapt a metacognition-based ConquerFear-HK to an internet-based self-management intervention, namely eConquerFear-HK and evaluate in a randomised controlled trial, its feasibility, utility, and potential effectiveness on fear of cancer recurrence reduction among local Chinese cancer survivors with subclinical fear of cancer recurrence.

NCT ID: NCT06206070 Recruiting - Clinical trials for Autism Spectrum Disorder

The Westmead Feelings Program Intervention for Chinese Children With Autism Spectrum Disorder in Hong Kong

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

The goal of this intervention is to evaluate the effectiveness of delivering the Westmead Feelings Program 2 to children with Autism Spectrum Disorder in primary schools in Hong Kong.

NCT ID: NCT06205004 Recruiting - Internet Addiction Clinical Trials

Prevalence of Internet Addiction and it's Effects on Psychological Well-being of Adults in Hong Kong

Start date: May 19, 2023
Phase:
Study type: Observational

The goal of this quantitative study is to learn about the the prevalence of internet addiction and its effects on psychological well-being of adults in Hong Kong. The main question it aims to answer is: • What is the prevalence of internet addiction and its effects on psychological well-being of adults in Hong Kong Participants will be invited to complete a set of questionnaire that includes assessment on their level of Internet use, depression, anxiety, sleep quality, QOL together with basic demographic data in the current situation of COVID with popularity of Metaverse..

NCT ID: NCT06204562 Recruiting - Aging Well Clinical Trials

Feasibility and Effects of Laughter-imitation Therapy (LIT)

Start date: August 16, 2023
Phase: N/A
Study type: Interventional

Background: The mental wellbeing of the institutional population has to be promoted, particularly after the serious hit by the pandemic. Objectives: 1. To develop a LIT intervention to promote mental wellbeing of institutional older adults 2. To explore the feasibility and acceptability of such intervention; 3. To explore the potential effect of the intervention Design and subject: A pilot cluster randomized control trial will be conducted. The target population is institutional older adults. About 30 participants will be recruited from 2 nursing homes. The intervention is one-month imitated laughter practice. Each practice session lasts for 3 minutes once a day, giving a total of 21 minutes per week and the waitlist control group will be under usual care for the first 8 weeks. Then, they will start intervention after the 8 week, and receive two additional outcome assessments. A brief one-to-one training will be offered and a trained research assistant (RA1). Further in-person demonstration and return demonstration will be conducted until participant is able to demonstrate the Duchenne smile on their own. RA1 will be on-site for two days in the first week and one day in the second week to support the participants. At the end of the intervention, qualitative feedback will be collected from purposive sample until data saturation. Instruments: Chinese version including the World Health Organization Five Well-Being Index (WHO-5), 4-item Subjective Happiness Scale (SHS), Geriatric Depression Scale (GDS), Pittsburgh Sleep Quality Index (PSQI), 5-min Montreal Cognitive Assessment, FRAIL scale, Geriatric Adverse Life Events Scale (GALES). Main outcome measures: Feasibility and acceptability of laughter-imitation therapy (LIT) Data analysis: Descriptive statistics will be calculated for participants' characteristics, practice frequency, satisfaction, and health outcomes. Linear mixed-effects models will be used to evaluate health outcomes. Content analysis will be conducted for qualitative feedback. Expected results: The intervention is expected to be feasible and acceptable to institutional older adults as a means for promoting mental wellbeing, and potential beneficial effects will be demonstrated.

NCT ID: NCT06203548 Recruiting - Fatty Liver Clinical Trials

Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

Background: Non-alcoholic fatty liver disease (NAFLD) affects 30% of the Asian adult population and is emerging as one of the important leading causes of liver cancer and cirrhosis. Although a number of biomarkersmany have been developed for the assessment of liver fat and fibrosis, most existing studies were cross-sectional in nature. The role of these biomarkers for monitoring and response assessment remains elusive. At present, magnetic resonance imaging proton density fat fraction (MRI-PDFF) is considered the gold standard to in quantifying liver fat. The MRI-PDFF response, defined as a ≥30% relative reduction in liver fat fraction, has been shown to correlate with improved hepatic inflammation and fibrosis. However, MRI is limited by cost and availability. The cContinuous controlled attenuation parameter (CAPc) measurement by vibration controlled transient elastography is a new technology to quantify liver fat. It is a point-of-care test and has the potential to replace the MRI-PDFF as a monitoring and response biomarker in routine practice. Study plan: This prospective cohort study will include 150 patients with NAFLD who will join a 6-month lifestyle modification programme involving dietary intervention and physical training. This will create a cohort of varying degrees of liver fat reduction. Using MRI-PDFF as the reference standard, we will evaluate the accuracy of a changes in CAPc in reflecting the MRI-PDFF response and remission of NAFLD, with all non-invasive tests performed at screening and Month 6. In addition, we will test the hypothesis that the the change in CAPc is superior to the change of in other steatosis tests results (including the original CAP, abdominal ultrasonography and steatosis scores of fatty liver index, hepatic steatosis index, NAFLD liver fat score and NAFLD ridge score) in predicting the MRI-PDFF response. The area under the receiver-operating characteristics curve of the CAPc response in predicting the MRI-PDFF response will be compared with that of the other steatosis tests using the DeLong test.

NCT ID: NCT06199674 Recruiting - Orthodontics Clinical Trials

Effects of PBM on Fixed-appliance Orthodontic Patients

Start date: January 20, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effects of photobiomodulation therapy (PBM) on the dental and periodontal health of patients undergoing fixed-appliance orthodontic treatment, including orthodontically induced root resorption, orthodontic pain, space closing rate, and dental microbiome profile in dental plaques.

NCT ID: NCT06195969 Recruiting - Stroke Clinical Trials

Instant Message-guided Hypertension Management Intervention Among Stroke Survivors

Start date: November 13, 2023
Phase: N/A
Study type: Interventional

This pilot and feasibility study aims to develop an automated instant message-delivered intervention (i.e., EMI) for hypertension management in stroke survivors, and to investigate the feasibility and effectiveness of the intervention.